Huntington's disease (HD) is a neurodegenerative disease caused by a CAG repeat expansion in exon 1 of the HD gene, and the expression level of either normal or mutant huntingtin is implicated in the pathogenesis of HD. However, a molecular base of the HD gene transcription has not been elucidated as yet. In this study, we identified two proteins, HDBP1 and HDBP2, which bind to the promoter region for the HD gene using a yeast one-hybrid system. Amino acid sequence analysis of the proteins deduced the presence of nuclear localization signal, nuclear export signal, zinc finger, serine/ proline-rich region, and highly conserved C-terminal region. In vitro DNA binding assay indicated that the C-terminal conserved regions of the proteins were responsible for binding to the unique promoter DNA sequences of the HD gene. The DNA sequence protected from DNase I digestion was a 7-bp consensus sequence (GCCGGCG), which resides in triplicate at intervals of 13 bp within and proximal to the 20-bp direct repeat sequences of the HD promoter region. The mutation of 7-bp consensus sequence abolishes the HD promoter function in a neuronal cell line (IMR32). In human cultured cells, ectopically expressed green fluorescent protein-fused HDBP1 and HDBP2 localized in the cytoplasm, but both proteins totally shift from cytoplasm to nucleus by the treatment with an inhibitor of the nuclear export, leptomycin B, and mutagenesis of the putative nuclear export signals. Taken together, HDBP1 and HDBP2 are novel transcription factors shuttling between nucleus and cytoplasm and bind to the specific GCCGGCG, which is an essential cis-element for HD gene expression in neuronal cells.
Huntington's disease (HD) 1 is an autosomal dominant neurodegenerative disorder characterized by involuntary movements, cognitive impairment, and emotional disturbance (1) . HD is caused by an expansion of the CAG trinucleotide repeat within exon 1 of the HD gene, which encodes a cytoplasmic protein named huntingtin (2) . The number of CAG repeats is polymorphic, ranging from 6 to 35 on normal chromosomes and 36 or more on HD chromosomes. The CAG trinucleotide repeat is translated into polyglutamine (polyQ). Expression of the mutant huntingtin carrying an expanded polyQ tract induces the formation of the nuclear and cytoplasmic aggregates in the brain, as well as in peripheral tissues of HD patients (3) (4) (5) . However, the question as to whether the role of the aggregates is protective or pathogenic remains to be solved.
Several lines of evidences from in vitro experiments as well as HD model mice suggest that a gain of toxic property acquiring in the mutant huntingtin is a major cause for HD pathogenesis. Recently, it has been shown that the expanded polyQ binds to a group of transcription factors, such as Sp1, cAMPresponsive element-binding protein-binding protein (CBP), p300/CBP-associated factors (P/CAF), and TAF II 130 (6 -13) , and could perturb their normal functions. This could lead to transcriptional dysregulation in a number of genes under controlling by these transcription factors, and ultimately to dysfunction of the cells. Thus, one of the possible toxic entities could be the ability of polyQ for binding to several transcription factors. To alleviate the pathology seen in HD, removing or reducing such toxic entities is one of the challenges in the development of disease therapies for HD as well as other polyQ diseases such as spinocerebellar ataxias and dentatorubral pallidoluysian atrophy. However, molecular mechanisms underlying the dysregulation of cellular systems, including the downstream signaling pathways mediated by the mutant huntingtin, remain elusive.
Several studies using animal models for HD have given important insights into the pathogenesis and cure for HD. Using YAC transgenic mice as a HD model, Leavitt et al. (14) have reported that normal huntingtin competes against mutated huntingtin to reduce the toxicity, suggesting that an increment of normal huntingtin could delay disease progression. On the other hand, the study of the conditional mouse model of HD using the tetracycline-responsive gene system demonstrated that a blockade of expression of mutated gene in symptomatic mice led to a disappearance of aggregates and an amelioration of the behavioral phenotypes, indicating that a continuous expression of the mutated huntingtin was required to maintain aggregate formation, as well as some symptoms, and that HD may be reversible (15) . Taken together, the levels of normal and mutated huntingtin may influence severity and progression of the disease. It is feasible to intervene in the progression or even to cure the disease by means of the manipulation of the mutated and/or normal huntingtin gene expression. As a first step toward this, comprehension of the molecular basis of the HD transcriptional regulation should be a primary objective.
To delineate the transcriptional regulation for the HD gene, we must perceive: 1) the structure of the promoter region including unique cis-regulatory elements, 2) trans-acting factors that bind to these cis-regulatory elements, and 3) how these factors contribute to induce or suppress its expression in the cells. Thus far, several studies on the structure and/or sequences for the promoter region of the HD gene have been published. The HD promoter region consists of a GC-rich DNA sequence containing several potential binding sites for Sp1, AP2, and AP4, whereas it lacks both typical TATA and CAAT boxes (16, 17) . There are two copies of the 20-bp direct repeat and two copies of the 17-bp direct repeat in the 5Ј region of the HD gene (17) . These unique repeat sequences have postulated to be cis-regulatory elements, which contribute to the regulation of transcription of the HD gene. In particular, the 20-bp direct repeat sequences are shown to be required for the enhanced transcription (18) . However, no trans-acting factors that bind to these candidate cis-regulatory elements on the HD promoter have been identified yet, let alone understanding the molecular mechanisms by which the transcription of the HD gene is regulated.
To aid in the delineation of the transcriptional regulation of the HD gene, we sought to explore trans-acting factors that bound to the promoter region of the HD gene. We report in this study the identification of two members of a novel nuclear shuttle protein family, HD gene regulatory region-binding protein (HDBP) 1 and HDBP2, which are found to be an exact match of GLUT4 enhancer factor DNA binding domain (GEFdb) (19) and papillomavirus binding factor (PBF) (20) , respectively. Both factors specifically bind to the triplicated 7-bp consensus sequence (GCCGGCG) at intervals of 13 bp in the HD promoter region. The HD promoter function, especially in a neuronal cell line (IMR32), relies on the 7-bp consensus sequence. These novel DNA-binding proteins in conjunction with the novel cis-regulatory element, GCCGGCG, can trigger off HD gene transcription in a neuronal cell line. These elements provide new clues to the understanding of the transcriptional regulation of the HD gene in neuron.
EXPERIMENTAL PROCEDURES
Reagent-Nuclear export signal (NES) inhibitor leptomycin B (LMB) (21, 22 ) was a gift from Dr. Minoru Yoshida (University of Tokyo, Tokyo, Japan).
Yeast One-hybrid Screening-The Matchmaker one-hybrid system (Clontech) was used to isolate cDNA clones encoding DNA-binding factor for the promoter region of the HD gene. A plasmid DNA containing 2.0 kilobase pairs of 5Ј-flanking region of the HD gene with (CAG) 18 (23) was used as a template for the PCR amplification. To generate target reporter construct for library screening, the DNA fragment containing the 5Ј-flanking region and a portion of exon 1 of the HD gene, corresponding with the nucleotide sequences from Ϫ365 to ϩ158, was amplified by PCR using the primer pair 5Ј-GTTGAGCCCCGCGCCT-TCG-3Ј and 5Ј-GGCTGAGGAAGCTGAGGAG-3Ј. The amplified fragment was inserted into the SmaI sites of pHISi-1 and pHISi reporter vectors, resulting in target-reporter constructs, pHISi-1-R1-2-3-4 and pHISi-R1-2-3-4, respectively. Yeast transformants containing either pHISi-1-R1-2-3-4 or pHISi-R1-2-3-4 reporter construct were established by transforming a yeast YM4271 strain with XhoI-linearized pHISi-1-R1-2-3-4 or pHISi-R1-2-3-4, followed by the selection on the SD/ϪHis medium. Then, human testis Matchmaker cDNA (GAL4 activation domain) library (pACT2 library) was introduced into these reporter strains. Transformants growing on SD/ϪHis/ϪLeu medium containing 45 mM 3-aminotriazole (3-AT) were isolated as positive clones (pACT2 clones), encoding the DNA-binding protein. Isolation of cDNA from yeast transformants was performed according to the protocol from the manufacturer (Clontech).
To confirm DNA binding activity and its specificity among the positive clones, additional reporter strains carrying smaller DNA fragments, R1 (Ϫ365 to Ϫ214), R2 (Ϫ231 to Ϫ113), R3 (Ϫ131 to ϩ51), and R4 (ϩ29 to ϩ158), were generated by PCR amplification using the primer pairs 5Ј-AAAGAATTCGTTGAGCCCCGCGCCTTCG-3Ј/5Ј-AAA-TGCGCAACGCCGGCCAGCATGATT-3Ј, 5Ј-AAAGAATTCAATCATG-CTGGCCGGCGT-3Ј/5Ј-AAATGCGCAAGCGGCCGTCCATCTTGGA-3Ј, 5Ј-AAAGAATTCTCCAAGATGGACGGCCGCT-3Ј/5Ј-AAATGCGCAGA-AGGACTTGAGGGACTCGAAGG-3Ј, and 5Ј-AAAGAATTCCCTTCGA-GTCCCTCAAGTCCTTC-3Ј/5Ј-AAATGCGCAGGCTGAGGAAGCTGA-GGAG-3Ј, respectively. Each amplified fragment was digested with EcoRI and MluI and inserted into both pHISi-1 and pHISi reporter vectors, resulting in eight target-reporter constructs, pHISi-1-R1, pHISi-R1, pHISi-1-R2, pHISi-R2, pHISi-1-R3, pHISi-R3, pHISi-1-R4, and pHISi-R4. Reporter strains were established by transforming a yeast YM4271 strain with XhoI-linearized constructs, followed by the selection on the SD/ϪHis medium plate. After re-transformation of each reporter strain with the positive cDNA (pACT2 clone) clone, the DNAprotein interaction was assayed by the growth of transformants on the SD/ϪHis/ϪLeu medium plate containing 45 mM 3-AT.
Isolation of the Entire Coding Sequence of Transcripts-To isolate full-length cDNA for HDBP1, 1.5 ϫ 10 5 plaque-forming units of the human testis cDNA library (insert size: larger than 0.5 kb) was screened by the standard procedure (Stratagene). In brief, phage plaques were plated, lifted and fixed onto nylon filters, and hybridized with the 32 P-labeled 1.3-kb HDBP1 cDNA fragment for 18 h in hybridization solution (2ϫ PIPES buffer, 50% deionized formamide, 0.5% SDS, 100 g/ml herring testis) at 42°C. The filters were washed twice for 5 min in 2ϫ SSC at room temperature and for 30 min in 0.1ϫ SSC, 0.1% SDS at 55°C. Autoradiography was performed for 1-2 days using x-ray film (Eastman Kodak Co., BioMax) at Ϫ80°C. The resulting positive phage clone was converted into plasmid DNA (pBluescript II; pBs) by in vivo excision (Stratagene), resulting in pBs-HDBP1.
To obtain the most 5Ј sequence of the HDBP2 transcript, rapid amplification of cDNA ends (RACE) was performed using SMART TM RACE cDNA amplification (Clontech). First strand cDNA was synthesized from the human testis mRNA using 5Ј-RACE cDNA synthesis primer. Twenty-five cycles of 5Ј-RACE and nested PCR reactions (94°C for 30 s; 68°C for 3 min) were carried out using 5Ј-ACCCCCGTACCA-CACATAAACCTTC-3Ј and an universal primer mix (Clontech), and 5Ј-GGTGCTGGGAGCCTTAAGGACT-3Ј and a nested universal primer (Clontech), respectively. The 350-bp PCR product was cloned using TA cloning system (Invitrogen). The fragment containing the entire open reading frame (ORF) of HDBP2 was generated from pACT2 clone 8 by PCR using primers c8ATG (5Ј-AAAGAATTCATGGCGAGTGTCCTGT-CCCGACGCCTTGGAAAGCGGTCCCTCCTGGGAGCCCGGGTGTTG-GGACCCAGTGCCT-3Ј) (initiation ATG is underscored) and c8stop (5Ј-AAAGTCGACTCAGTCCAGAAAGCGCTG-3Ј). The PCR fragment was digested with EcoRI and SalI and inserted into the EcoRI-SalI site of pBs vector, resulting in pBs-HDBP2.
cDNA Sequencing and Sequence Analysis-DNA sequence of the cDNA clones was determined using a DyeDeoxy Terminator Cycle Sequencing kit and ABI377 DNA sequencer (ABI). The cDNA and predicted amino acid sequences were compared with non-redundant nucleotide and protein sequence data base using BLASTN and BLASTP (blast.genome.ad.jp/) (35), respectively. The multiple protein sequence alignment was performed using GENETYX-MAC.
Northern Blot Analysis-The filters of Gene Hunter I, II, III, and IV (non-normalized) (Toyobo) were used for Northern blot analysis. The 1.3-kb HDBP1 cDNA, the 1.7-kb HDBP2 cDNA, and the full-length ␤-actin cDNA were labeled with [␣- 32 P]dCTP by a random priming method. Hybridization with each labeled probe was carried out in a solution (0.5 M sodium phosphate (pH 7.2), 7% SDS, 1 mM EDTA) for 18 h at 65°C. Filters were washed once for 5 min in 2ϫ SSC at room temperature and for 30 min in 2ϫ SSC, 1% SDS at 65°C. Autoradiography was performed for 1-2 days using x-ray film (Kodak BioMax) at Ϫ80°C.
Generation of the Plasmid Constructs-Expression constructs for HDBP1 and HDBP2 as glutathione S-transferase (GST)-, green fluorescent protein (GFP)-, and MycHis-tagged fusion proteins were generated as follows. Template plasmid DNA (10 ng) was subjected to 25 cycles of PCR amplification (30 s at 94°C and 3 min at 68°C) using KOD polymerase (Toyobo) and primers (Table I) . Each fragment was digested with EcoRI and XhoI (GST-fused HDBPs and MycHis-tagged fused HDBPs) or EcoRI and SalI (GFP-fused HDBPs) and inserted into the EcoRI-XhoI site of pGEX-5X-1 or -5X-2 (Amersham Biosciences) and pcDNA3.1-MycHisC (Clontech), or the EcoRI-SalI site of pEGFP-N1 (Clontech). A firefly luciferase reporter plasmid was constructed as follows. The fragments (Ϫ231 to Ϫ146) with wild-type and mutated 7 bp in R2 region were generated by PCR using the template DNA, pHISi-R2, and the primer pairs 5Ј-AAAACGCGTAATCATGCTGGCCGGCGT-3Ј/5Ј-AAAC-TCGAGCCCCACGGCGCCTTGCGTCCCAGA-3Ј and 5Ј-AAAACGCGT-AATCATGCTGGCAAGCGTGGCCCCGCCTCCGCAAGCGCGGCCCC-GCCTCCGCAAGCGCAGCGTCT-3Ј/5Ј-AAACTCGAGCCCCACGGCG-CCTTGCGTCCCAGA-3Ј (mutations are underscored), respectively.
Each amplified fragment (wt-7bp and m3-7bp) was digested with MluI and XhoI and inserted into pGV-E2 reporter vector (Toyo Inc.), resulting in two reporter constructs, pGV-E2-wt-7bp/Luc and pGV-E2-m3-7bp/Luc.
Electrophoretic Mobility Shift Assays (EMSA)-A series of the GSTfused HDBP1 and HDBP2 was expressed in Escherichia coli strain BL21(DE3)-pLysS in the presence of 0.1 mM isopropyl-1-thio-␤-D-galactopyranoside and 100 M zinc chloride, and purified using GSTrap (Amersham Biosciences) according to the protocol from the manufacturer. Probe DNAs were prepared by digesting the pHISi-1 plasmid containing R1, R2, R3, or R4 fragments with the EcoRI-MluI site and the pGV-E2 plasmid containing wt-7bp or m3-7bp fragment with the MluI-XhoI site and then labeled with [␣- Binding reaction was performed in binding buffer (20 mM Tris-HCl (pH 7.6), 50 mM KCl, 10% glycerol, 1 mM DTT, 2 g poly(dI-dC)⅐poly(dIdC) (Amersham Biosciences)). GST fusion proteins were incubated in binding buffer for 5 min at room temperature with or without competitor DNAs. The 32 P-labeled probe (0.1 ng) was then added and incubated for another 20 min at room temperature. DNA-protein complexes were resolved on 4% polyacrylamide gels in 0.5ϫ TBE (45 mM Tris borate, 1 mM EDTA) at 120 V for 2 h. Gels were dried under vacuum and exposed to Kodak x-ray film.
DNase I Footprinting-The 253-bp DNA fragment of the HD promoter region was amplified by PCR using primer pair 5Ј-AAAACGCG-TGTTGAGCCCCGCGCCTTCG-3Ј and 5Ј-AAAACTCGAGAGCGGCCG-TCCATCTTGGA-3Ј, and cloned using a TA cloning system (Invitrogen), followed by digestion with MluI and XhoI. The MluI-XhoI fragment was isolated, end-labeled with 32 P, and used for DNase I footprinting. Binding reaction was performed in a total volume of 20 l of binding buffer (20 mM Tris-HCl (pH 7.6), 50 mM KCl, 10% glycerol, 1 mM DTT, 2 g poly(dI-dC)⅐poly(dI-dC) (Amersham Biosciences)). The 32 P-end-labeled DNA fragment (1 ng) was mixed with GST-HDBPs-C (10, 50, 200, and 400 ng) and incubated for 20 min at room temperature. Two l of 10ϫ DNase I solution (15 g/ml DNase I, 50 mM MgCl 2 ) was added, incubated for additional 1 min at 25°C, and followed by the addition of DNase I stop solution (1.6 M ammonium acetate, 95 mM EDTA, 0.8% SDS, 0.3 mg/ml calf thymus DNA). The DNA mixture was treated with phenol-chloroform and precipitated with ethanol. Precipitated DNA was dissolved in loading dye (80% formamide, 10 mM EDTA (pH 8.0), 0.025% bromphenol blue, 0.025% xylene cyanol). The samples were electrophoresed on an 8 M urea, 8% acrylamide gel. Sequence ladders (GϩA and TϩC) were generated by standard chemical sequencing techniques of Maxam and Gilbert.
Measurement of Reporter Gene Activity by Luciferase Assay-HeLa and IMR32 cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen) and minimum essential medium (Invitrogen) with 10% fetal bovine serum (FBS) in 5% CO 2 humidified atmosphere at 37°C, respectively. Cells were plated by 36 h before transfection at a density of 1 ϫ 10 5 cells/well (HeLa) and 1 ϫ 10 6 cells/well (IMR32) in 6-well culture plates. HeLa and IMR32 cells were transfected with 100 and 500 ng of pGV-E2-wt-7bp/Luc or -m3-7bp/Luc and 5 and 25 ng of pRL-TK (Nippon Gene) using FuGENE6 transfection reagent (Roche Applied Science), respectively. After incubation for 24 h, cells were washed with phosphate-buffered saline and lysed with 1ϫ lysis buffer (Promega). Luciferase assays were carried out according to the protocol from the manufacturer using the dual luciferase reporter assay system (Promega) and TR717 Microplate Luminometer (PerkinElmer Applied Biosystems). The firefly luciferase activity was normalized to the control sea pansy luciferase activity to control for variations in transfection efficiency (24) . 
Subcellular Localization Analysis of GFP Fusion Proteins-HeLa

TABLE I The list of HDBP1-and HDBP2-specific primers, vectors, and template DNAs used for PCR amplification
transfected with 1 g of the pHDBP-GFP expression plasmids using an Effectene TM transfection reagent (Qiagen). IMR32 cells were plated by 36 h before transfection at a density of 2.5 ϫ 10 5 cells/well on 2-well chamber slide (Nunc) and were transfected with 1 g of the pHDBPs-GFP expression plasmids using FuGENE 6 transfection reagent (Roche Applied Science). After 24 h, HeLa and IMR32 cells were fixed with 4% paraformaldehyde, and were examined for subcellular localization of GFP fusion proteins under a fluorescence microscopic observation (DM-REB; Leica) and confocal microscopic observation (TCS_NT confocal microscope systems; Leica), respectively. To examine effects of leptomycin B, transfected cells were treated with 10 ng/ml leptomycin B for 1 h after 24 h of transfection.
Mutagenesis of the HDRF1 and HDRF2 Clones-Two amino acid substitution mutations were introduced into pHDBP1-MycHis and pHDBP2-MycHis by GeneEditor TM in vitro site-directed mutagenesis system (Promega) using the following mutagenic oligonucleotides: hdrf1 (L257A/L260A), 5Ј-GATGTTGGTGTGGACACGCTGACCGACG-GGGCGTCCAGCGCGACTCCAGTGTCCCCCACGGCCTCCATGCCG-3Ј; hdrf1 (F273A/L276A), 5Ј-GTGTCCCCCACGGCCTCCATGCCGCCT-GCCGCCCCCCGCGCGGAGCTGCCAGAGCTGCTGGAGCCCCCAGC-C-3Ј; hdrf2 (L109A/L113A), 5Ј-TGGATGGAGGGTCAGGTGACCGTCT-GGCTGGCGGAGCAGAAGGCGCAGGTCTGCTGCAGGGTGGAGGA-GGTGTGG-3Ј; hdrf2 (M169A/M172A), 5Ј-GAAGTCGGACGCAGTGGA-AATGGATGAGATGGCGGCGGCCGCGGTGCTGACGTCCCTGTCCT-GCAGCCCTGTTG-3Ј (mutations are underscored). The resulting mutants, pHDBP1(L257A/L260A)-MycHis, pHDBP1(F273A/L276A)-MycHis, pHDBP2(L109A/L113A)-MycHis, and pHDBP2(M169A/M172A)-MycHis, were confirmed by DNA sequencing analysis. To generate GFP fusion expression constructs with mutations, the fragments were amplified from pHDBP1(L257A/L260A)-MycHis and pHDBP1(F273A/ L276A)-MycHis using the primer pair hdrf1gF/hdrf1gR, and from pHDBP2(L109A/L113A)-MycHis and pHDBP2(M169A/M172A)-MycHis using the primer pair hdrf2F/hdrf2R. Each fragment was digested with EcoRI and SalI and inserted into the EcoRI-SalI site of pEGFP-N1 vector (Clontech), resulting in pHDBP1(L257A/L260A)-GFP, pHDBP1(F273A/L276A)-GFP, pHDBP2(L109A/L113A)-GFP, and pHDBP2(M169A/M172A)-GFP.
RESULTS
Identification of Proteins That Bind to the Promoter Region of
the HD Gene-To explore the promoter-binding proteins of the HD gene, we performed a yeast one-hybrid screening with a human testis Matchmaker cDNA (GAL4 activation domain) library using a yeast reporter strain containing the bait R1-2-3-4 DNA fragment (Fig. 1A) . Thirty-three positive clones (pACT2 clones) have been isolated so far. Five of these clones represented the same cDNA (pACT2 clone 2, ϳ1.3-kb cDNA size, GenBank TM accession no. AB044786) (Fig. 1B) , and the other two clones represented independent cDNAs, pACT2 clone 8 (ϳ1.7-kb cDNA size, GenBank TM accession no. AB044750) (Fig. 1B) and pACT2 clone 11, respectively. 2 The rest of 26 clones are false positives, which neither carry in-frame coding . Potential Sp1 and AP2 binding sites within the R1 region between nucleotides Ϫ365 and Ϫ214 have been reported. Two copies of 20-bp direct repeat (gray boxes) and two transcriptional start sites, both of which are present within the R2 region between nucleotides Ϫ231 and Ϫ113, are also shown. R3 and R4 contain a portion of exon 1 of the HD gene, spanning the regions between nucleotides Ϫ131 and ϩ51 and between nucleotides ϩ29 and ϩ158, respectively. The number of the CAG repeat in the R4 fragment is 18 repeats. Adenine of the translation start site (ATG) is numbered as ϩ1. Three filled boxes indicate 7-bp protected core sequences (GCCGGCG: HDBP1 and HDBP2 binding sites) found by DNase I footprinting (see Fig. 6 ). B, four yeast reporter strains carrying a bait DNA fragment of R1-2-3-4, R1, R2, R3, or R4 were used for the yeast one-hybrid assay. Each reporter strain was re-transformed with plasmid DNA of pACT2 clone 2/HDBP1 or pACT2 clone 8/HDBP2, and was cultured on SD/ϪHis/ϪLeu medium containing 45 mM 3-AT. A yeast reporter strain that was transformed with pHISi-1 empty-vector alone was used as a control.
sequences nor re-grow on the SD/ϪHis/ϪLeu/ϩ3-AT medium. On the other hand, the reporter strain containing the bait DNA in a reverse orientation (R4-3-2-1, Fig. 1A ) gave no positive clone.
To refine the binding regions of three representative clones (pACT2 clones 2, 8, and 11), we further carried out the yeast one-hybrid assay using four yeast reporter strains containing the bait DNA of R1 (Ϫ364 to Ϫ214), R2 (Ϫ231 to Ϫ114), R3 (Ϫ131 to ϩ51), and R4 (ϩ29 to ϩ158) DNA fragment (Fig. 1A) , respectively. Both pACT2 clone 2 and pACT2 clone 8 revealed strong binding to the R2 region in the promoter of the HD gene (Fig. 1B) . In addition, they also showed weak binding activity to the R1 region, indicating that they bind to an overlap region (Ϫ231 to Ϫ214) between R1 and R2 or that there are several distinct binding sites within R1 and R2 regions. On the other hand, pACT2 clone 11 was shown to associate with the R3 region (data not shown). As both pACT2 clone 2 and pACT2 clone 8 revealed specific binding to the promoter region of the HD gene, we characterized these two clones in detail.
Isolation of the Transcripts Encoding HDBP1 and HDBP2-Based upon the sequence analysis, the 1.3-kb cDNA of pACT2 clone 2 appears to be a part of transcript; therefore, we screened further a human testis cDNA library using the 1.3-kb cDNA as a probe to obtain a full-length transcript. Two independent cDNA clones, whose inserts are ϳ1.5 and 1.8 kb long, respectively, were identified. DNA sequence analysis revealed that the 1.8-kb cDNA encompassed 1,776 nucleotides (nt) with a single ORF encoding a 46-kDa protein of 387 amino acids (GenBank TM accession no. AB052777). As 1.8 kb of the cDNA is equivalent to the size of the transcript represented by Northern blotting (see Fig. 2A ), the 1.8-kb cDNA might contain the entire sequence of the transcript. We thus designated this gene product as HDBP1 (Huntington's disease gene regulatory regionbinding protein 1).
DNA sequencing of the 1.5-kb cDNA (pACT2 clone 8) revealed that the termination codon was included within the sequence, but no authentic initiation codon for methionine was found. Therefore, 5Ј-RACE using a human testis cDNA library was carried out to obtain the most upstream of the 5Ј sequence of the transcript including the initiation codon and 5Ј-untranslated region (UTR). Several clones comprising the initiation codon and the 5Ј-UTR were identified (data not shown). The composite DNA sequence of pACT2 clone 8 transcript encompasses 1,874 nt with a single ORF and is predicted to encode a 62-kDa protein consisting of 513 amino acids (GenBank TM accession no. AB073627). Northern blot analysis demonstrated that the transcript for the pACT2 clone 8 was ϳ5.0 kb long (Fig.  2B) , indicating that this composite cDNA sequence was still missing a portion of 3Ј-UTR. Despite of this fact, pACT2 clones 8 obviously contain the entire coding region, and the gene product was designated as HDBP2.
Tissue Distribution of mRNAs Encoding HDBP1 and HDBP2-The expression level and distribution of the transcripts encoding HDBP1 and HDBP2 were analyzed by Northern blot analysis with mRNAs extracted from various human tissues. Both transcripts are ubiquitously expressed, but with significantly less expression in brain and ileum (Fig. 2, A and B) .
Data Base Searches and Deduced Amino Acid Sequences of HDBP1 and HDBP2-The genes coding for HDBP1 and HDBP2 have been named and registered as SLC2A4 and ZNF395, respectively (HUGO Gene Nomenclature Committee). Data base search of the deduced amino acid sequences for HDBP1 and HDBP2 was performed using a BLASTP program. The middle region of HDBP1 amino acid sequence (387 aa), corresponding to 68 -293 aa, was found to be an exact match of GEFdb (GLUT4 enhancer factor DNA-binding domain) (19) (Fig. 3A) . The 236-amino acid sequence for GEFdb filed is apparent that it is deduced from a partial mRNA sequence and lacks an initiation codon and also most part of the N-terminal sequences as well as corresponding amino acid sequences to the C-terminal region of HDBP1. Thus, GEFdb may be a potential splice variant of HDBP1. It is also revealed that HDBP2 is the same protein that has been known as papillomavirus binding factor PBF, which play a role in papillomavirus genes' transcription and in E2-mediated repression (20) . Homology search in conjunction with the multiple alignments of the protein sequences showed that the overall homology of the amino acid sequences between HDBP1/GEFdb and HDBP2/PBF was significantly high with a 36% identity (Fig. 3A, DNASIS-Mac 3.5) . Moreover, mouse glucocorticoid-induced gene 1 (GIG1) (GenBank TM accession no. AF292939) was found to be highly homologous to both HDBP1and HDBP2 (Fig. 3A) . HDBP1, HDBP2, and GIG1 proteins share the similar domain structures: a single zinc finger domain (C 2 H 2 type), several putative nuclear localization signals (NLSs) and nuclear export signals (NESs), serine-rich region (SRR), proline-rich region (PRR), and three highly conserved regions (CR1, CR2, and CR3), implying functional similarity to one another. The predicted CR1, CR2, and CR3 peptide sequences among the proteins are 54 -70, 68 -86, and 84 -86% identities, respectively (Fig. 3B) . Taken together, these data imply that HDBP1 and HDBP2 belong to a novel protein family.
The C-terminal Conserved Region (CR3) of HDBP1 and HDBP2 Interacts with DNA-To confirm the DNA-protein interaction observed in the yeast one-hybrid screening, we examined whether HDBP1 and HDBP2 proteins bind to the promoter region of the HD gene in vitro. GST fusion HDBP1 and HDBP2 proteins prepared from E. coli were subjected to EMSA using 4 HD promoter DNA fragments (R1, R2, R3, and R4; Fig.  1A ) as probes. Equal amounts of GST-fused HDBP1 and HDBP2 peptides were used in this binding experiment (Fig. 5A,  arrowhead) . By the addition of the varied amount of purified GST-HDBP1, the intensity of signals representing DNA-protein complexes was increased in a protein-concentration-dependent manner with fixed amount of 32 P-labeled R2 and R3 probes, but not with R1 or R4 probes (Fig. 4A) . To prove the specific bindings, a competition assay was performed. Both GST-HDBP1 bindings to the R2 and R3 probes were preferentially competed by the addition of unlabeled R2 but not significantly by R3 (Fig. 4B) . The binding of GST-HDBP1 to R3 probe implies as a result of an overlap of 19 bp on each probe or some sequence similarity between R2 and R3 (detailed below). EMSA and the competition analysis also revealed the specific binding of GST-HDBP2 to the R2 probe, but not to the R1, R3, or R4 (Fig. 4, C and D) . These results are consistent with the result of the one-hybrid screening (Fig. 1B) . However, weak binding activities to the R1 region in one-hybrid experiment (Fig. 1B) were not confirmed by the in vitro binding experiments. It could be because of a weak and/or unstable interaction of HDBP1/HDBP2 with R1. In fact, there is an overlap of 18 bp on R1 and R2, and one of the triplicate DNA binding sequences resides in the overlapping region (detailed in the following section).
To define HDBP1/HDBP2 DNA-binding domains, which mediate the interaction with R2 DNA fragment, we prepared three truncated peptides of HDBP1 fused with GST, GST-HDBP1-N (1-105 aa), GST-HDBP1-Zn (106 -321 aa), and GST-HDBP1-C (322-387 aa), and three truncated peptides of HDBP2 fused with GST, GST-HDBP2-N (1-168 aa), GST-HDBP1-Zn (169 -437 aa), and GST-HDBP1-C (438 -513 aa) for the EMSA. DNA-protein complexes were formed with only GST-HDBP1-C but not GST-HDBP1-N or GST-HDBP1-Zn (Fig. 5B) . The EMSA using a series of truncated HDBP2 peptides also represented the DNA-protein complexes formation with the C-terminal peptide, GST-HDBP2-C (438 -513 aa), but not others (Fig. 5C ). For further analysis of the DNA-binding domains, we prepared the GST fusion peptides consisting of the conserved C-terminal amino acid sequences (CR3; 37 aa) of HDBP1 (351-387 aa) and HDBP2 (477-513 aa). Both CR3 peptides were found to retain binding activities to the R2 probe (Fig. 5D) . Moreover, these complex formations were specifically competed out by the addition of unlabeled R2 (Fig. 5E ). These results demonstrate that highly conserved CR3 region in the C terminus of HDBP1 and HDRF2 is the DNA-binding domain and directly interacts with the R2 region of the HD promoter. As a protein sequence for CR3 matches to none of the publicly available motif/domains listed so far, CR3 might be a novel DNA-binding domain.
HDBP1 and HDBP2 Bind to the Unique DNA Sequence-To determine the DNA sequence that interacts with HDBP1 and FIG. 3 . Comparison of the deduced amino acid sequences of GEFdb, HDBP1, HDBP2, and GIG1. A, amino acid sequence alignment was carried out using multiple alignment system of GENETYX-MAC. Amino acid residues matched in three or four proteins are shown with asterisk at the bottom of the alignment, and those matched in two proteins are shown with dot at the bottom of the alignment. Dashes represent gaps in the sequence alignment. The sequences are numbered with the predicted initiation methionine codon of HDBP1, HDBP2, or GIG1 designated 1. Most Nterminal residue of GEFdb was designated as 1, as it was deduced from the partial cDNA sequence. Putative NES motifs, putative NLS motifs, a serine-rich region (SRR), a proline-rich region (PRR), a single zinc-finger domain (ZNF), and three CR are represented by the gray, red, orange, purple, green, and blue shadings, respectively. B, multiple amino acid sequence alignment of CR1, CR2, and CR3 among HDBP1/GEFdb, HDBP2, and GIG1. Percentage of the identities in CRs between HDBP1 and HDBP2, HDBP2, and GIG1, and HDBP1 and GIG1 are shown on the right of the sequence alignment. Amino acid residues that matched among all three proteins are shown in bold letters.
HDBP2, DNase I footprint analysis was achieved using a 253-bp DNA fragment (R1-2), corresponding to nucleotides Ϫ365 to Ϫ113 of the HD promoter sequence, in the presence of GST-HDBP1-C and GST-HDBP2-C. The footprint patterns exhibited the strongly protected sequences at three regions (nucleotides Ϫ221 to Ϫ215, Ϫ201 to Ϫ195, and Ϫ181 to Ϫ175) (Fig.  6 ) and a weakly protected sequence (nucleotide Ϫ142 to Ϫ136; data not shown) by the addition of either GST-HDBP1-C or GST-HDBP2-C. All three strongly protected sequences are the same as the consensus sequence (C/G)GCCGGCG(C/T). One copy of the consensus sequence resides in each of the duplicated 20-bp direct repeats, and the third one resides at proximal to the repeat. The 20-bp direct repeat sequence has been postulated as an enhancer element for HD transcription; thus, the 7-bp consensus sequence in triplicate at 13-nucleotide intervals is a potential cis-regulatory core element.
The weakly protected sequence (nucleotide Ϫ142 to Ϫ136) is GCCGGGA. In addition, another similar sequence as GC-CGGGC is in R3 (nucleotide Ϫ18 to Ϫ12). This single copy of 7-bp sequences in R3 might be the cause of the weak interaction with HDBP1 and HDBP2 in vitro experiments as described above.
To confirm further the binding between the 7-bp consensus sequence and HDBP1/HDBP2 molecules is specific, we generated radioactive 86-bp DNA fragments carrying with a wild type sequence of the 7-bp consensus sequences (wt-7bp) and a mutated 7-bp consensus sequence of GCAAGCG in all of three consensus sequences (m3-7bp) respectively, and performed EMSA with purified GST-HDBP1-C and GST-HDBP2-C. The mutation introduced into three consensus sequences abolished DNA-HDBP1/HDBP2 complexes formation (Fig. 7A) . The bindings of GST-HDBP1 and GST-HDBP2 to the wt-7bp probe were competed by the addition of excess amount of the unlabeled wt-7bp, but not by the unlabeled m3-7bp (Fig. 7B) , indicating that the 7-bp consensus sequence was the specific site recognized by HDBP1 and HDBP2.
According to the binding analysis of PBF, PBF recognized the sequence CCGG in papillomavirus genomes (20) . However, it is apparent to our in vitro binding assay that HDBP2 does not bind to the sequence CCGG in R1 (nucleotides Ϫ345 to Ϫ342 and Ϫ220 to Ϫ217) (Fig. 4C) .
7-bp Consensus Sequence Is Essential for the HD Promoter Activity in a Neuronal
Cell Line-The study of the HD promoter has demonstrated that the 20-bp direct repeat in the promoter is required for enhanced transcription (18) . In this report, we identified a novel cis-regulatory core element with the 7-bp consensus sequence repeat in triplicate including the 20-bp direct repeat (Fig. 6) . To know whether the 7-bp consensus sequence repeat in triplicate is required and acts as a cis-regulatory element for the HD promoter function in vivo, we carried out luciferase reporter gene assays in a non-neuronal (HeLa; human epitheloid carcinoma) and a neuronal (IMR32; human neuroblastoma) cell lines. The reporter constructs with the wild-type and mutated 7-bp consensus sequences as described above were generated (pGV-E2-wt-7bp/Luc, pGV-E2-m3-7bp/Luc; Fig. 8A ) and transfected to the cells. Each of the promoter activities in HeLa and IMR32 cells was represented as a relative luciferase activity normalized to the control sea pansy luciferase activity (Figs. 8, B and C) . The HD promoter activity in HeLa cells was not significantly affected by the mutations of the 7-bp consensus sequence (Fig. 8B) ; however, the promoter activity in IMR32 cells relied on the 7-bp consensus sequence (Fig. 8C) . Thus, the HD promoter tends to comply with the 7-bp consensus sequence in a neuronal cell line but not in a non-neuronal cell line. These results imply that the 7-bp consensus sequence act as an essential cis-regulatory element in neuronal cells for the transcription steered by the HD promoter.
Subcellular Localization of Ectopically Expressed HDBP1/ HDBP2 in HeLa and IMR32 Cells-To investigate the subcellular localization of HDBP1 and HDBP2, we generated Nterminal fusion of HDBP1 and HDBP2 to GFP (HDBP1-GFP and HDBP2-GFP) (Fig. 9A) . The transient expression in HeLa cells exhibits that both proteins localize in the cytoplasm (Fig.  9B, control (Ϫ) ), and a nuclear localization of the GFP fusion proteins is observed in a small number of cells. On the other hand, an immunohistochemical analysis of the endogenous HDBP1 and HDBP2 is in preparation, and is waiting for antibodies against the proteins.
Several of the putative NES and NLS motifs are found in both HDBP1 and HDBP2; we examined whether these motifs are genuine. HeLa cells expressing HDBP1-GFP and HDBP2-GFP were treated with LMB, a specific inhibitor of the NES receptor Crm1 (21, 22) . LMB treatment (Fig. 9B, ϩLMB) resulted in nuclear localizations of HDBP1-GFP and HDBP2-GFP, implying that these proteins could be imported into the nucleus by their own NLS function and retained within the nucleus by inhibiting the Crm1-dependent nuclear exports.
We next examined the subcellular localization of HDBP1-GFP and HDBP2-GFP in IMR32 cells. When HDBP1-GFP and HDBP2-GFP were expressed transiently, both proteins localized in the cytoplasm (Fig. 9C, control (Ϫ) ) and in the nuclei (Fig. 9C, LMB) under non-treated and treated conditions with LMB, respectively. Consequently, distributions of HDBP1 and HDBP2 in IMR32 cells were identical to those in HeLa cells. These results demonstrate that both HDBP1 and HDBP2 possess functional NES as well as NLS, and shuttle between cytoplasm and nuclei through a NLS/NES-dependent pathway in either neuronal/non-neuronal cells.
Identification of Functional NES-The identification of a genuine NES among multiple NES motifs deduced in HDBP1 and HDBP2 was achieved by site-directed NES mutagenesis. HDBP1 contains four putative NES motifs. The N-terminal peptide (1-198 aa) carrying first and second putative NESs and the C-terminal peptide (199 -387 aa) carrying third and fourth putative NESs were expressed in HeLa and IMR32 cells as GFP fusion proteins. The N-terminal peptide localized only in the nuclei (Fig. 10A and data not shown) , suggesting that both first and second NESs are non-functional. This result parallels the function of NLS in N-terminal region of HDBP1. In fact, HDBP1 protein sequence search identified a candidate NLS at 187-193 aa. To confirm whether the third and/or fourth NES of HDBP1 are functional, we mutated both Leu-257 and Leu-260 to alanine residues obtaining the third NES mutant (HDBP1-L257A/L260A). We also mutated both Phe-273 and Leu-276 to alanine residues generating the fourth NES mutant (HDBP1-F273A/L276A). The ectopic expression of each C-terminal GFP fusion mutant protein in HeLa and IMR32 cells revealed that HDBP1-L257A/L260A localized in the nuclei, whereas HDBP1-F273A/L276A was in the cytoplasm (Fig. 10 (A and C) and data not shown). These results indicate that only a third NES (253-263 aa) of HDBP1 is functional indeed. In addition, the Cterminal peptide showed the nuclear localization after LMB treatment (data not shown), implying that the second NLS (351-354 aa) of HDBP1 is also functional candidate.
As HDBP2 carries two putative NES motifs, we generated the N-and C-terminal HDBP2 peptides (1-168 and 169 -513 aa, respectively) of GFP fusion protein-expressing constructs to determine the functional NES (Fig. 10B) . When each terminal peptide was expressed in HeLa and IMR32 cells, both the Nand C-terminal peptides showed the nuclear localization (Fig.  10B and data not shown) . Taking this result together with a fact that the second NES (165-174 aa) is split into the N-and C-terminal halves of HDBP2, the first intact NES is not functional and the second one may be a functional candidate. To confirm this, two NES mutants of HDBP2, HDBP2-L109A/ L113A and HDBP2-M169A/M172A, were generated and expressed in HeLa and IMR32 cells. HDBP2-M169A/M172A localized in the nuclei (Fig. 10, B and C) , whereas HDBP2-L109A/L113A was in the cytoplasm (Fig. 10B and data not  shown) . These results indicate that the second NES (165-174 aa) is functional. In addition, both putative NLSs (156 -162 and 267-273 aa) of HDBP2 seem to be functional, based upon the fact of the nuclear localization of N-and C-terminal halves of HDBP2 protein. a new aspect of the HD pathogenesis by means of perpetual expression of the mutated HD gene that might be a major causative for HD, and imply that HD is a reversible neurodegenerative disorder. Besides the unknown function of HD protein, molecular base of the transcriptional regulation of the HD gene in neurons has not been delineated as yet.
In this study, we identified two independent ubiquitously expressed genes, SLC2A4 and ZNF395, which encode proteins termed HDBP1 and HDBP2, respectively. Analysis of amino acid sequences of HDBP1 and HDBP2 revealed that both proteins are highly homologous and shared several motifs as well as the structural features including NLS, NES, a single zinc and F273A/L276A), in which indicated amino acid residues (Leu257and Leu-260 for the third NES, and Phe-273 and Leu-276 for the fourth NES) were substituted for alanine, were expressed in HeLa cells. B, schematic representation of transiently expressed HDBP2-GFP fusion proteins is shown. Full-length (1-513 aa), N-terminal half (1-168 aa), C-terminal half (169 -513 aa), and mutants (L109A/L113A and M169A/M172A), in which indicated amino acid residues (Leu-109and Leu-113 for the first NES, and Met-169 and Met-172 for the second NES) were substituted for alanine, were expressed in HeLa cells. C, wild-type full-length (1-387 aa) and mutant (L257A/L260A) of HDBP1-GFP fusion proteins and wild-type full-length (1-513 aa) and mutant (M169A/M172A) of HDBP2-GFP fusion proteins were transiently expressed in IMR32 cells. The localization of fusion proteins was observed by GFP fluorescence (GFP) and the nuclei were visualized by 4Ј,6-diamidino-2-phenylindole, dihydrochloride staining (DAPI). All images were obtained at a magnification of ϫ200 (A and B) and ϫ630 (C). finger motif of C 2 H 2 type, serine-rich region, proline-rich region, and the highly conserved C-terminal region (Fig. 3) . The biochemical analyses of HDBP1 and HDBP2 demonstrated that the highly conserved C-terminal region (CR3) of each protein contained the novel DNA-binding domain, which mediated the interaction to the region containing the unique 20-bp direct repeat, which is a potential enhancer for the HD promoter (18) (Fig. 4) . DNase I footprint analysis indicated that both novel DNA-binding domains for HDBP1 and HDBP2 recognized the heptanucleotide (GCCGGCG: 7-bp consensus sequence) in triplicate, which is located within and proximal to 20-bp direct repeats (Fig. 6 ). In addition, the specific binding between the 7-bp consensus sequence and HDBP1 (HDBP2) was confirmed by EMSA (Fig. 7) . These results imply that HDBP1 and HDBP2 are first candidate trans-acting factors coupled with the 7-bp consensus sequence, which is in triplicate at intervals of 13 bp in the HD promoter and is also a novel cis-regulatory element.
The mutation of 7-bp consensus sequence, GCCGGCG to GCAAGCG, not only obstructed HDBP1 (HDBP2) binding to the sequence but also abolished the HD promoter activity in a neuronal cell line, IMR32 (Fig. 8C) . Under the present condition of the HD promoter assay, IMR32 cells in non-differentiated phase may tend to less dose stringency of the 7-bp consensus sequences. However, the mutation of 7-bp consensus sequence did not significantly affect the HD promoter function in a non-neuronal cell line, HeLa (Fig. 8B) . It is noteworthy that the HD promoter relies on the 7-bp consensus sequence in a neuronal cell line but not in a non-neuronal cell line. These results imply that the 7-bp consensus sequence acts as an essential cis-regulatory element in neuronal cells for the transcription steered by HD promoter. Thus, these elements (HDBP1, HDBP2, and 7-bp consensus sequence) provide new clues to the understanding of the transcriptional regulation of the HD gene.
Moreover, a set of the triplicate DNA-binding 7-bp consensus sequence at 13-bp intervals may contribute to form a rigid HDBP1 (HDBP2)-DNA complex through a positive cooperative manner, and a complex with single copy of the 7-bp consensus sequence as well as similar (GCCGGGA/GCCGGGC) sequence is vulnerable to dissociation. In this study, we have no results yet to show that either single HDBP1 (HDBP2) molecule or polymeric HDBP1 and/or HDBP2 molecules bind to the triplicate 7-bp consensus sequences.
Data base searches found that a part of HDBP1 peptide sequence was an exact match of GEFdb playing role in a transcriptional regulation of the human GLUT4 gene (19) . However, GEFdb that has been cloned and sequenced so far seems to be a part of the full length of the peptide, lacking an initiation methionine (19) . Our data indicate that GEFdb could be a potential splice variant omitting the conserved C-terminal region of HDBP1, through which HDBP1 bound to the HD promoter (Fig. 3) . Conversely, HDBP1 might represent the fulllength polypeptide encoded by SLC2A4 gene. Nevertheless, it has been shown that GEFdb binds to DNA sequence ACCGG within the GLUT4 (19) . This implicates that each protein (HDBP1, GEFdb) has a distinct DNA-binding domain, which recognizes a unique DNA sequence and is implicated in the transcriptional regulation of the different genes (such as HD and GLUT4), possibly depending on different signaling pathways or tissue specificities. On the other hand, amino acid sequence of HDBP2 is an exact match of that of PBF (20) . Recent study has reported that PBF recognizes the sequence CCGG in the 3Ј half of the E2 binding site of papillomavirus genomes and has played a role in transcription of papillomavirus genes and in E2-mediated repression (20) . However, a significant correlation between the transcriptional regulation of the HD gene and that of papillomavirus genes is unclear. In addition, both HDBP1 and HDBP2 proteins share the similar domain structures (Fig. 3) , suggesting that HDBP1/GEFdb and HDBP2/PBF are members of the novel protein family. Data base searches also revealed that mouse GIG1 shared the several motifs and domain features, including a conserved Cterminal region, with those found in HDBP1 and HDBP2 (Fig.  3) . Although human homologue of GIG1 has not been identified yet, the function of GIG1 may be analogous to that of either HDBP1 or HDBP2. So far, it is unknown whether GIG1 interacts with the promoter region for the HD gene.
The 7-bp consensus sequence, GCCGGCG, in triplicate at intervals of 13 nucleotides is unique to the HD promoter gene, but a single copy of the 7-bp sequence is also found in other human genes. For example, the H ϩ /K ϩ -ATPase ␤ subunit gene (25) , thrombopoietin (TPO) gene (26) , p27
Kip1 gene (27) , and Werner's syndrome gene (WRN) (28) carry a single copy of the 7-bp sequence within their promoter regions. However, neither cis-regulatory elements nor trans-acting factors among these genes have been identified as yet. Our results using the reporter gene assay demonstrated that the 7-bp consensus sequence(s) was sufficiently effective in a neuronal cell line to promote the transcription of heterologous gene (Fig. 8, B and C). In addition, Sp1-like sites, which lie within 13-nucleotide intervals, are also associated with the enhanced transcription (18) . Thus, it is conceivable that both HDBP1 and HDBP2 are novel trans-acting factors, and the triplicate 7-bp consensus sequence at 13-bp intervals is a novel cis-regulatory element in the transcriptional regulation of HD gene.
To understand the transcriptional regulation of the HD gene via the interactions of HDBP1 and/or HDBP2 to the HD promoter, characterization of the subcellular distribution of these proteins is thought to be the first step. Unexpectedly, the ectopically expressed GFP-tagged HDBP1 and HDBP2 in HeLa and IMR32 cells localized in cytoplasm (Fig. 9, B and C) . However, LMB treatment induced rapid accumulation of GFP-HDBP1 and -HDBP2 in the nuclei (Fig. 9, B and C) . Moreover, the mutations in NES also led to the nuclear localization of HDBP1 and HDBP2 (Fig. 10) . These findings clearly show that both NESs in HDBP1 and HDBP2 are functional in either neuronal/non-neuronal cells.
The nuclear transport of protein factors is regulated by various stimuli such as phosphorylation and/or dephosphorylation (29) , stress response (24), or protein processing (30) . For instance, transcription factor has to be re-localized from the cytoplasm into the nuclei to modulate the expression of target genes (31, 32) . The nuclear localization of Aft1 transcription factor responds to iron status and leads to iron-regulated expression of the target genes, and NES associates with nuclear export of Aft1 (32) . Also, class II histone deacetylase 5 localizes in the nuclei in the dephosphorylated state and associates with MEF2 transcription factor to block expression MEF2 target genes (29) . In the phosphorylated state, histone deacetylase 5 is excluded from the nuclei through the NES-dependent pathway. In fact, we found a putative 14-3-3 protein binding site within the primary sequence of HDBP1 and HDBP2. As 14-3-3 protein plays critical roles in signal transduction pathways that control mitogen-activated protein kinase activation and gene expression (33) , it may regulate the nucleocytoplasmic transport of HDBP1 and HDBP2. Taken together, it is conceivable that HDBP1 and HDBP2 may shuttle between nuclei and cytoplasm through a NES-dependent pathway that is regulated by the specific signal transduction mediated by factors such as 14-3-3 protein. In particular, factor(s) that was specifically expressed in neuronal cells might influence the subcellular distribution of HDBP1 and HDBP2 in neuronal cell-specific manners, and HDBP1 and HDBP2 might interact with other neuronal cellspecific factors regulating the HD promoter activity in IMR32 cells.
Recently, functional differences in the HD promoter between neuronal and non-neuronal cell lines have been reported (18) . Furthermore, the HD gene expression seems to be regulated by Sp1 as well, because the Sp1 element is conserved in the HD promoter and 20-bp direct repeats also contain Sp1-like element (18) . Moreover, the 20-bp direct repeats in the human HD gene containing the 7-bp recognition sequence show polymorphisms in its copy number ranging from one to three copies (34) , suggesting that the bindings of HDBP1 and HDBP2 to the HD promoter may also be influenced by this polymorphism.
Future studies on HDBP1 and HDBP2 may provide new clues to the understanding of the neuron-specific transcriptional regulation of the HD gene and will pave the way toward the development of a novel therapy for HD.
